Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Nippon Shinyaku patents muscarinic acetylcholine M3 receptor positive allosteric modulators

June 9, 2021

BI-655064 does not meet CRR primary endpoint in lupus nephritis phase II trial

June 4, 2021

Pivotal study of venglustat in ADPKD stopped for futility

June 1, 2021

Targeting senescent cells restores kidney function

May 26, 2021

Regulus reports updated results from phase Ib study of RGLS-4326 in ADPKD

May 25, 2021

New phase Ib/IIa study evaluates VB-119 in membranous nephropathy

May 18, 2021

Dosing initiates in phase I study of GFB-024 in severe insulin-resistant diabetic nephropathy

May 14, 2021

Nephraegis Therapeutics to develop NPH-022 for the prevention and treatment of AKI

May 13, 2021

Phase III FIGARO-DKD cardiovascular outcomes study of finerenone meets primary endpoint

May 10, 2021

Benlysta approved in E.U. for active lupus nephritis

May 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...